Target intelligence / Profile preview

Gram-negative bacterial membrane phospholipids

Molecular classification
Lipid, Phospholipid
01

Overview

Gram-negative bacterial membrane phospholipids are essential structural components of both the inner and outer membranes of Gram-negative bacteria. The primary phospholipids include phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CL), which maintain the structural integrity and selective permeability of the cell envelope (Sohlenkamp & Geiger, 2016). In the outer membrane, these lipids are primarily located in the inner leaflet, while the outer leaflet is composed of lipopolysaccharides. These phospholipids serve as critical therapeutic targets for certain classes of antibiotics, most notably the polymyxins, which bind to the negatively charged lipid headgroups (Poirel et al., 2017). This binding disrupts the membrane's stability, leading to leakage of intracellular contents and rapid bacterial lysis (Trimble et al., 2016). Because these lipids are fundamental to bacterial survival and differ in composition from eukaryotic membranes, they provide a basis for selective toxicity, although high doses can lead to significant side effects in humans.

Other names
Bacterial phospholipidsGram-negative inner membrane phospholipidsGram-negative outer membrane phospholipidsPhosphatidylethanolaminePhosphatidylglycerolCardiolipin
02

Mechanism of action

Polymyxins act by binding to the negatively charged phosphate groups of phospholipids and lipopolysaccharides in the bacterial membranes. This interaction displaces divalent cations (calcium and magnesium) that stabilize the membrane, leading to increased permeability, membrane disruption, and cell death (Poirel et al., 2017).

03

Biological functions

Membrane integrityPermeability barrierCell divisionProtein anchoringSignal transduction
04

Disease associations

InfectionSepsisBacterial pneumoniaUrinary tract infection
05

Safety considerations

NephrotoxicityNeurotoxicityElectrolyte imbalanceHemolysis at high concentrations
06

Interacting drugs

Polymyxin B

2 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive proteinSerum creatinine (for toxicity monitoring)

Beyond the preview

Go deeper on Gram-negative bacterial membrane phospholipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial membrane phospholipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call